Anitoa Systems
Hangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Developer of portable, CMOS-based molecular diagnostic systems for point-of-care infectious disease testing.
Infectious Disease
Technology Platform
Ultra-sensitive CMOS biosensor chips integrated with microfluidic cartridges to create portable, low-cost real-time PCR systems.
Opportunities
Significant growth potential in decentralized testing for primary care clinics and low-resource regions globally.
Risk Factors
Commercial execution risk against dominant incumbents and potential pricing pressure in the crowded diagnostics market.
Competitive Landscape
Competes with large diagnostics firms (e.g., Abbott, Roche) and other point-of-care molecular device companies on the basis of cost, portability, and ease of use.